Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Clinical Medicine|January 11, 2024
Myocarditis and Chronic Inflammatory Cardiomyopathy, from Acute Inflammation to Chronic Inflammatory Damage: An Update on Pathophysiology and DiagnosisGiuseppe Uccello, Giacomo Bonacchi, Valentina Alice Rossi, et al.BMC Medical Genetics|August 13, 2016
TAS2R38 taste receptor gene and chronic rhinosinusitis: new data from an Italian populationStefania Gallo, Sarah Grossi, Giulia Montrasio, et al.Journal of Bone and Joint Infection|March 3, 2020
Oral Flucloxacillin for Treating Osteomyelitis: A Narrative Review of Clinical PracticeHelga Preiss, Philipp Kriechling, Giulia Montrasio, et al.Life (Basel, Switzerland)|January 21, 2023
Multimodality Imaging in Sarcomeric Hypertrophic Cardiomyopathy: Get It Right…on TimeAlessandro Galluzzo, Francesca Fiorelli, Valentina A Rossi, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 21, 2017
Evaluation of a protocol for same-day discharge after radial lounge monitoring in a southern Swiss referral percutaneous coronary intervention centreLuigi Biasco, Giovanni B Pedrazzini, Marco Araco, et al.Journal of Clinical Medicine|December 23, 2022
Biventricular Arrhythmogenic Cardiomyopathy Associated with a Novel Heterozygous <i>Plakophilin-2</i> Early Truncating VariantTolga Çimen, Verena C Wilzeck, Giulia Montrasio, et al.European Heart Journal. Quality of Care & Clinical Outcomes|May 22, 2026
Heart failure guideline-directed medical therapy in young adults with dystrophin-related cardiomyopathy: the HOPE-MD registryLuca Monzo, Emanuele Bobbio, Giulia Montrasio, et al.Atherosclerosis|April 23, 2021
Reduced adrenal stress response in patients on PCSK9 inhibitor therapySimon Meier, Marcel Frick, Michael Liu, et al.Vascular Pharmacology|October 1, 2022
Prevalence and risk of inappropriate dosing of direct oral anticoagulants in two Swiss atrial fibrillation registriesGiulia Montrasio, Martin F Reiner, Andrea Wiencierz, et al.Nutrients|March 6, 2021
The Omega-3 Fatty Acid Eicosapentaenoic Acid (EPA) Correlates Inversely with Ischemic Brain Infarcts in Patients with Atrial FibrillationMartin F Reiner, Philipp Baumgartner, Andrea Wiencierz, et al.Pageof 1